British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging Facility, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; National Health Service Lothian, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging Facility, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; National Health Service Lothian, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
J Am Coll Cardiol. 2018 Feb 6;71(5):513-523. doi: 10.1016/j.jacc.2017.11.053.
Fluorine-18-sodium fluoride (F-NaF) uptake is a marker of active vascular calcification associated with high-risk atherosclerotic plaque.
In patients with abdominal aortic aneurysm (AAA), the authors assessed whether F-NaF positron emission tomography (PET) and computed tomography (CT) predicts AAA growth and clinical outcomes.
In prospective case-control (n = 20 per group) and longitudinal cohort (n = 72) studies, patients with AAA (aortic diameter >40 mm) and control subjects (aortic diameter <30 mm) underwent abdominal ultrasound, F-NaF PET-CT, CT angiography, and calcium scoring. Clinical endpoints were aneurysm expansion and the composite of AAA repair or rupture.
Fluorine-18-NaF uptake was increased in AAA compared with nonaneurysmal regions within the same aorta (p = 0.004) and aortas of control subjects (p = 0.023). Histology and micro-PET-CT demonstrated that F-NaF uptake localized to areas of aneurysm disease and active calcification. In 72 patients within the longitudinal cohort study (mean age 73 ± 7 years, 85% men, baseline aneurysm diameter 48.8 ± 7.7 mm), there were 19 aneurysm repairs (26.4%) and 3 ruptures (4.2%) after 510 ± 196 days. Aneurysms in the highest tertile of F-NaF uptake expanded 2.5× more rapidly than those in the lowest tertile (3.10 [interquartile range (IQR): 2.34 to 5.92 mm/year] vs. 1.24 [IQR: 0.52 to 2.92 mm/year]; p = 0.008) and were nearly 3× as likely to experience AAA repair or rupture (15.3% vs. 5.6%; log-rank p = 0.043).
Fluorine-18-NaF PET-CT is a novel and promising approach to the identification of disease activity in patients with AAA and is an additive predictor of aneurysm growth and future clinical events. (Sodium Fluoride Imaging of Abdominal Aortic Aneurysms [SoFIA]; NCT02229006; Magnetic Resonance Imaging [MRI] for Abdominal Aortic Aneurysms to Predict Rupture or Surgery: The MA3RS Trial; ISRCTN76413758).
氟-18-氟化钠(F-NaF)摄取是与高危动脉粥样硬化斑块相关的活跃血管钙化的标志物。
在腹主动脉瘤(AAA)患者中,作者评估了 F-NaF 正电子发射断层扫描(PET)和计算机断层扫描(CT)是否可预测 AAA 生长和临床结局。
在前瞻性病例对照(每组 20 例)和纵向队列(n=72)研究中,AAA(主动脉直径>40mm)和对照受试者(主动脉直径<30mm)接受腹部超声、F-NaF PET-CT、CT 血管造影和钙评分。临床终点为动脉瘤扩张和 AAA 修复或破裂的复合事件。
与同一主动脉内的非动脉瘤区域(p=0.004)和对照受试者的主动脉(p=0.023)相比,AAA 中氟-18-NaF 摄取增加。组织学和微-PET-CT 显示 F-NaF 摄取定位于动脉瘤疾病和活跃钙化区域。在纵向队列研究中的 72 例患者中(平均年龄 73±7 岁,85%为男性,基线时动脉瘤直径 48.8±7.7mm),510±196 天后发生了 19 次动脉瘤修复(26.4%)和 3 次破裂(4.2%)。氟-18-NaF 摄取最高三分位的动脉瘤扩张速度比最低三分位快 2.5 倍(3.10[四分位间距(IQR):2.34 至 5.92mm/年]比 1.24[IQR:0.52 至 2.92mm/年];p=0.008),并且发生 AAA 修复或破裂的可能性几乎高出 3 倍(15.3%比 5.6%;对数秩 p=0.043)。
氟-18-氟化钠 PET-CT 是一种新颖且有前途的方法,可用于识别 AAA 患者的疾病活动,并可作为动脉瘤生长和未来临床事件的附加预测指标。(腹部主动脉瘤的氟[18F]氟化钠成像[SoFIA];NCT02229006;磁共振成像(MRI)预测腹主动脉瘤破裂或手术:MA3RS 试验;ISRCTN76413758)。